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ABSTRACT
Objectives: The aging population is expected to increase
the burden of osteoporosis on the US health-care system.
We developed a methodology for estimating current
and future costs of osteoporosis in state populations and
applied it to Florida.
Methods: We used Florida hospital, population and
mortality data, along with national data on outpatient
and long-term care, to estimate the cost of osteoporotic
fractures in the year 2000. For men and for “other” frac-
tures in women, costs were based on the incidence of
hospital admissions for fractures. For hip, spine, and
wrist fractures in women, we integrated hospital and
nonhospital fracture incidence in a Markov model of
osteoporosis. Consecutive cohorts were run by race for
each age, 50 to 99 years, to estimate the number and
cost of incident fractures. Ongoing costs of prevalent
fractures in women were estimated using postfracture
health states for each individual age cohort. Total costs
and fractures for the years 2001 through 2025 were pro-
jected by multiplying the base-year cost and fracture
distribution by age-, sex-, and race-speciﬁc population
growth rates.
Results: In Florida, 86,428 osteoporotic fractures were
estimated to occur in the year 2000 at a cost of
$1,238,445,114. By 2025, the estimated number of inci-
dent fractures would increase to 151,622, at a cost of
$2,135,130,564.
Conclusions: This disease-modeling approach generates
detailed information on the current and future cost
burden of osteoporosis for an individual state popula-
tion. Predictions based on this methodology may enable
health-policy decisions that are tailored to local needs.
Keywords: burden, costs, fractures, health policy,
Markov model, osteoporosis, race.
Introduction
The medical cost of osteoporosis and related frac-
tures in the United States is estimated to range from
$11.6 to $17.3 billion per year, adjusted to 2001
dollars [1–5]. Nevertheless, little is known about
the cost of osteoporosis at the state level and the
future impact of growth in the senior population.
Local data may enhance planning and evaluation of
interventions to manage the disease and control
health-care expenditures. Nearly two-thirds of
states have established osteoporosis education pro-
grams or task forces, and many state legislatures
have mandated a needs assessment. Two states, Illi-
nois and Pennsylvania, have published reports on
hospital costs [6,7], and one journal article reports
the burden of osteoporosis in California [8]. To help
states plan current and future resource allocation
over the next 25 years, we developed a methodol-
ogy that can be applied to individual states and used
for comparisons among states. The objectives were
to evaluate costs by site of service, age, and race
group, as well as to predict cost increases and the
impact of future demographic shifts.
Our approach was designed to address several
challenges to researchers evaluating the epidemio-
logy and costs associated with osteoporotic frac-
tures. First, the widespread underdiagnosis of
osteoporosis can result in gross underestimation of
costs. Total costs are driven primarily by hip frac-
tures; however, even for hip fracture, a diagnosis of
osteoporosis is rarely indicated in hospital records
[9,10]. Another cause of underestimation is the
failure to capture long-term costs of fractures. In
addition, the limited availability of state data on
outpatient and long-term care (LTC) costs is an
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obstacle to assessing overall medical cost at the state
level. Finally, lack of a standard methodology has
precluded valid comparisons among states.
To address underdiagnosis of osteoporosis in
men and women, we focused on fracture costs and
used published attribution rates, rather than oste-
oporosis diagnosis codes, to determine the propor-
tion of total fractures that are attributable to
osteoporosis. These attribution rates are based on
work by Melton et al. [11] using a Delphi process
with a panel of physicians highly experienced in
the treatment and diagnosis of osteoporosis. For
women, we supplemented this approach with a
Markov model that simulates the natural history
of osteoporosis. Our application included a new
method of capturing the fracture history of a spe-
ciﬁc population to determine costs of prevalent
(pre-existing) as well as incident (new) fractures. We
applied this methodology to the state of Florida,
which has the nation’s second largest senior popu-
lation. The National Osteoporosis Foundation esti-
mates that Florida has 3.01 million women and men
with osteoporosis or osteopenia (low bone mineral
density) in 2002, and prevalence will increase by
25% to 3.77 million in 2010 and by 56% to 4.72
million in 2020 [12].
Methods
We developed a methodology to estimate the cur-
rent and future burden of osteoporosis for a state
population aged 50 years and older. Whenever pos-
sible, we used state-speciﬁc data, including age- and
sex-speciﬁc population, mortality, and all-payer
hospital discharge data. For both sexes and all frac-
ture types, costs included Florida hospital costs and
estimates of posthospital care based on Florida hos-
pital discharge data and published national statis-
tics. In addition, for hip, spine, and wrist fractures
in women, the availability of overall fracture inci-
dence data enabled use of a Markov state-transition
model of osteoporosis to better estimate costs after
both incident and prevalent fractures. Although our
reliance on events linked to hospitalization under-
estimates the cost of fractures in men and other
(nonhip, nonspine, nonwrist) fractures in women,
this approach provides a total estimate of disease
burden that is valuable to state policymakers [6,7].
Only medical costs and direct nonmedical costs, for
example, transportation for long-term disability,
were included in the analysis because data were
unavailable to accurately assess indirect costs such
as caregiver time, and lost work time is generally a
minor cost for a senior population [8].
Description of the Model
The Markov state-transition model of osteoporosis
simulates the natural history of osteoporosis in
women beginning at the age of 50 years and con-
tinuing through the age of 99 years. In the model, a
cohort is followed as it transitions from a healthy
state to a healthy, fracture, or dead state, using 1-
year cycles. Long-term consequences after a hip
or spine fracture are captured using postfracture
health states. Outcomes after hip fracture are
assumed to dominate those associated with other
types of fracture. Individuals are limited to two hip
fractures per lifetime. This model was developed
and validated using age-speciﬁc hip, spine, and
wrist fracture data and age-speciﬁc mortality data
for women in the United States, Canada, and
Sweden [13].
Epidemiology Inputs
The epidemiology inputs included population
size, mortality rates, and fracture incidence rates.
We used population data for the following race/
ethnic groups, hereafter referred to as “race”: non-
Hispanic white, non-Hispanic black, Hispanic
white, Hispanic black, and other. Age-speciﬁc pop-
ulation data for men and women aged 50 through
99 years in Florida from 2000 through 2025 were
obtained from a census publication [14], which
accounted for all forms of in-migration, out-
migration, and mortality. General population mor-
tality rates for men and women aged 50 through
99 years in Florida were obtained from the Centers
for Disease Control, National Center for Health
Statistics [15]. For the Markov model, age-speciﬁc
excess mortality rates associated with hip fractures
in women were obtained from a study conducted in
the United Kingdom [16] because age-speciﬁc rates
were not available for individual states or for the
entire United States.
Florida hospital and population data were used
to calculate incidence rates for hip and other frac-
tures in men and women aged 50 through 99 years,
as well as spine and wrist fractures in men [17]. For
hip fractures, hospital incidence represents overall
incidence. For spine [18] and wrist [19] fractures in
women, overall incidence includes hospital and
nonhospital incidence rates that were obtained from
an epidemiologic study conducted in Rochester,
Minnesota. The spine fracture rates indicate total
fractures that would be detected by radiograph.
Because the Rochester population may not be rep-
resentative of the racial mix in Florida, we evalu-
ated alternative incidence rates by race in the
sensitivity analysis. Table 1 summarizes fracture
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incidence rates for women by age group and race,
before and after downward adjustment using
Melton’s osteoporosis attribution rates [11]. Note
that incidence rates by individual age were used in
the analysis. The attribution rates were applied as
follows: white rates for non-Hispanic whites and
white Hispanics, black rates for non-Hispanic
blacks and black Hispanics, and other rates for
other race groups.
Cost Inputs
We used the 1998 Florida AHCA Inpatient Data
File in estimating inpatient, outpatient, and LTC
costs for men and women. We selected cases with a
primary admission diagnosis of fracture on the dis-
charge record (ICD-9 codes for closed hip fracture
[733.14, 808.0x, 808.2x, 808.4x, 808.8x, 820.0x,
820.2x, 820.8x]; closed spine fracture without spi-
nal cord injury [733.13, 805.0x, 805.2x, 805.4x,
805.8x], wrist fracture [733.12, 813.xx], or other
fracture [733.1x and 800.xx−829.xx, excluding
those for hip, spine, wrist]). For hip fractures, we
also incorporated published estimates of the costs of
acute inpatient physician services [20], hospital
readmissions [20,21], and rehabilitation and short-
stay hospitalization [20,21]. For spine fractures,
costs for inpatient physician services were estimated
using the physician service utilization proﬁle from
the literature [20] and the 2000 Medicare Fee
Schedule.
In the Markov model, the mean inpatient costs
for wrist fractures in women were multiplied by
0.10 [3] to adjust overall fracture incidence rates for
the low proportion of wrist-fracture patients who
receive inpatient care. For spine fractures, a factor
of 0.425 was applied to noninpatient costs [22,23]
to reﬂect the proportion of radiographically detect-
able spine fractures that receive medical care. A
larger reduction factor of 0.123 (= 0.29 × 0.425)
was used for inpatient costs, based on an estimate
that 29% of clinical spine fractures are admitted to
inpatient hospitals [23,24]. For men, downward
adjustments to spine and wrist fracture costs were
unnecessary because these costs were based on inpa-
tient hospital admissions.
Outpatient costs for hip and spine fractures
included posthospitalization physician visits [21]
and medical and nonmedical home care [21]. For
wrist and other fractures, outpatient costs were
estimated by taking the national proportion of out-
patient to inpatient costs [1] and multiplying by the
corresponding mean Florida inpatient fracture
costs.
The expected costs of LTC for hip fractures were
derived by multiplying the probability of using LTC,
estimated from Florida hospital discharge data,
weighted by length of stay for partial and full-year
stays [20,21], by the per diem cost of $124 [25,26].
National estimates for disability and dependency
care costs [21] were summed together with LTC
facility costs to create total expected LTC costs dur-
ing the ﬁrst year after a hip fracture. The ongoing
costs for LTC and disability/dependency care after
the ﬁrst year were obtained from the literature [21].
For nonhip fractures, a national proportion of LTC
to inpatient care costs [1] by fracture type was
Table 1 Annual fracture incidence rates per 10,000 Florida women, by age and race group and fracture type
Race Fracture
Age (years) 
50–64 65–74 75–84 ≥85
Unadj.* Adj.† Unadj.* Adj.† Unadj.* Adj.† Unadj.* Adj.†
White‡ Hip§ 8.7 7.0 36.5 32.8 131.3 118.2 391.2 371.6
Spine|| 59.3 47.4 166.2 149.6 309.2 278.2 447.0 424.7
Wrist¶ 48.7 34.1 60.6 42.4 53.3 37.3 68.8 55.1
Black‡ Hip§ 3.8 2.5 17.5 14.0 55.5 44.4 164.9 156.6
Spine|| 57.9 37.7 161.2 129.0 306.2 245.0 447.0 402.3
Wrist¶ 48.0 26.4 59.6 35.7 53.2 31.9 68.8 48.2
Hispanic# Hip§ 4.9 3.8 25.3 22.6 115.1 103.0 330.6 314.1
Spine|| 59.2 46.9 162.4 145.4 307.9 276.1 447.0 424.0
Wrist¶ 48.7 33.7 59.8 41.6 53.2 37.1 68.8 54.9
Other‡ Hip§ 16.8 12.6 45.0 38.3 369.5 314.1 1268.3 1204.8
Spine|| 56.3 42.2 160.4 136.4 303.9 258.3 447.0 424.7
Wrist¶ 47.0 28.2 59.4 41.6 53.0 37.1 68.8 48.2
*Incidence rates were weighted by population within age group and race. Rates are reported here by age group, whereas the analysis employed incidence rates by
individual age.
†Incidence rates adjusted using age/race-speciﬁc attribution probabilities for each fracture type [11].
‡Excludes any race with Hispanic ethnicity.
§Incidence rates calculated from 1998 Florida Hospital Inpatient Data File and population from US Census Bureau.
||Melton et al. [18].
¶Melton et al. [19].
#Includes any race with Hispanic ethnicity.
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multiplied by the respective mean fracture cost in
Florida.
Table 2 shows expected unit costs for each frac-
ture type by age and sex. A detailed description for
hip fracture is provided in Appendix 1. All unit
costs were converted into year 2000 terms using the
Medical Care Component of the urban Consumer
Price Index [27].
Calculation of Base-Year Costs and 25-Year Projections
In the Base Year 2000, for men, the total cost of
fractures was calculated based on the incidence
of hospital admissions for all fracture types. For
women, total cost was based on hospital incidents
for hip and other fractures and based on overall
fracture incidence rates, hospital and nonhospital,
for wrist and spine fractures. Future costs and frac-
tures for the years 2001 through 2025 were pro-
jected by multiplying the base-year cost and fracture
distribution by the respective age-, sex-, and race-
speciﬁc population growth rates. All projections
were in real terms, reﬂected the cost structure in
2000, and assumed that the true rate of inﬂation
was equal to the real rate of interest.
For women, the base year included costs of prev-
alent hip and spine fractures, which were estimated
by an iterative process. For each race group, white,
black, Hispanic white, Hispanic black, and other,
we ran the Markov model 50 times, once for each
age cohort 50 through 99 years of age. Incident
fracture costs were obtained from the ﬁrst year of
follow-up, and disease history was simulated by
tracking younger cohorts, up to a maximum of 25.
For example, for the cohort of 65-year-old persons,
the younger cohorts of 50- to 64-year-old persons
were “aged up” to 65 years, and posthip and post-
spine fracture costs were determined for each of
these cohorts at 65 years of age. Costs from previ-
ous fractures, which reﬂect age-speciﬁc mortality
and fracture incidence rates, were averaged over the
number of contributing cohorts.
Results
Fractures accounted for 43,520 admissions to
Florida hospitals in 1998. After adjustment for
osteoporosis attribution probabilities and elimina-
tion of high-cost outliers, osteoporotic fractures
accounted for 32,255 admissions to Florida hospi-
tals in 1998 (Table 3). Osteoporotic hip fractures
resulted in approximately 68% of admissions, spine
fractures in 12%, wrist fractures in 3%, and other
fractures in 17%. These fractures accounted for
172,814 hospital bed days and nearly $574 million
in hospital charges. Patients with hip fracture had a
mean length of stay of 5.9 days, and 61% were dis-
charged to a LTC facility. Patients with spine frac-
Table 2 Expected unit costs ($) for fractures, by sex and age
Cost category
Age (years)
Women Men
50–64 65–74 75–84 ≥85 50–64 65–74 75–84 ≥85
Hip fractures
Inpatient* 25,038 20,505 21,663 21,400 30,087 23,805 23,401 24,139
Outpatient† 2,408 2,122 2,142 2,137 2,494 2,220 2,213 2,225
LTC, ﬁrst year 8,992 13,387 15,501 15,526 7,772 10,559 13,630 13,715
LTC, years >1 4,323 4,323 4,323 4,323 — — — —
Spine fractures‡
Inpatient 1,452 1,486 1,277 1,450 12,086 7,637 7,141 6,138
Outpatient 296 296 294 296 368 328 324 314
LTC, ﬁrst year 115 118 101 115 1,048 660 617 527
LTC, years >1 115 118 101 115 — — — —
Wrist fractures§
Acute inpatient hospital 905 1,061 1,053 1,430 12,806 10,235 8,340 10,377
Outpatient 460 539 535 727 840 671 547 680
LTC, ﬁrst year 203 238 236 320 2,869 2,293 1,868 2,325
Other fractures
Acute inpatient hospital 16,438 16,466 14,778 13,360 17,662 18,344 14,638 14,843
Outpatient 2,823 2,828 2,538 2,295 3,304 3,149 2,514 2,549
LTC, ﬁrst year 6,542 6,553 5,881 5,317 7,029 7,296 5,825 5,907
*Includes inpatient facility, inpatient physician, readmission, and rehabilitation/short-stay costs for women.
†Includes outpatient visits, home health care, and nonmedical home care.
‡For women, inpatient costs multiplied by 12.3% and all other costs multiplied by 42.5% before use in the model. Costs for men were not factored down, because
radiographic incidence rates were not used for men.
§For women, inpatient costs multiplied by 10% (to reﬂect the proportion of all wrist fractures admitted to an inpatient hospital) before use in model, which employed
overall incidence (hospital and non-hospital) rates. Costs for men were not factored down, because overall incidence rates were not used for men.
Abbreviation: LTC, long-term care. Includes LTC facility and disability/dependency.
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ture had a mean length of stay of 4.7 days, and 42%
were discharged to a LTC facility.
The projected total medical cost of osteoporosis
in 2000 was nearly $1.24 billion (Table 4). People
aged 50 to 64 years represented approximately 8%
of total medical costs, those aged 65 to 74 years
accounted for 16%, those aged 75 to 84 years com-
prised 36%, and those aged 85 years and older
accounted for 39%. Inpatient costs made up the
majority of the total costs ($689.2 million [56%]),
followed by LTC ($452.8 million [37%]) and out-
patient care ($96.4 million [8%]). Across age
groups, the proportion of costs as a result of out-
patient care was nearly equivalent (8%), whereas
LTC appeared to represent a higher share of total
costs among older patients. Speciﬁcally, LTC com-
prised 24% of costs in the 50- to 64-year age group,
32% in the 65- to 74-year age group, 37% in the
75- to 84-year age group, and 41% in the 85-year-
and-older age group.
Total annual costs were projected to increase
from the base year 2000 level of $1.24 billion to
$1.54 billion (24%) in 2010 and $2.14 billion
(72%) in 2025 (Table 5; Fig. 1). The total number
of osteoporotic fractures was projected to increase
from 86,428 in 2000, to 107,026 (24%) in 2010,
and to 151,622 (75%) in 2025. Hip fracture events
were projected to increase by almost 72% by 2025,
and spine fractures by 77%. Although hip fractures
comprised the majority of costs, spine fractures
accounted for about 51% of all osteoporotic frac-
tures. Spine fractures resulted in only 8% of total
costs because most of these cases do not come to
medical attention, and most of those that do receive
medical care are treated in lower cost outpatient
settings.
Women represented more than $927 million
(75%) of the total annual medical care costs in
2000 and were projected to reach $1.6 billion in
2025. The costs for men were about $311 million
in the base year and were predicted to be nearly
$529 million by 2025. By race, whites had over
73,000 fractures for over $1 billion (87%) in 2000.
By 2025, total fractures and costs for white persons
increase by about 50%, but total share of the pro-
jected $2.1 billion cost falls to 74%. The “other”
race group has the lowest share of the total cost
(2%) in 2000 but shows the largest growth rate.
Hispanic and black persons account for 8.1 and
2.8% of the base year costs, increasing to 16.2 and
3.9%, respectively, by 2025. For Hispanic persons
in the age groups 65 years and older, hip fracture
incidence rates are 69% to 88% of the rates in
white persons (Table 1). Thus, both population
growth and fracture incidence contribute to the pre-
dicted growth in total fractures and costs for His-
Table 3 Mean and total gross charges, hospital days, and percentage discharged to LTC for osteoporotic fractures in men and
women aged 50 years and older, admitted to Florida hospitals during 1998*
Fracture
type
Number of
hospital
admissions†
Hospital costs ($) Length of stay (days) Discharges
to LTC 
facility (%)Mean SD Total Mean SD Total
Hip 21,827 20,614 14,699 447,782,267 5.9 4.8 127,512 61
Spine 3,991 8,992 5,806 35,707,626 4.7 2.9 18,743 42
Wrist 1,044 12,136 6,121 12,522,002 2.9 1.7 3,024 24
Other 5,394 14,707 10,000 77,952,650 4.3 3.3 23,536 38
Total 32,255 17,383 23,677 573,964,545 5.2 5.7 172,814 54
*Florida Hospital Inpatient Data File, State of Florida Agency for Health Care Administration, 1998.
†Total admissions after applying osteoporosis attribution probabilities by age, sex, and race. An additional 1194 high-cost cases were excluded (21 hip, 357 spine,
101 wrist, 715 other).
Abbreviation: LTC, long-term care.
Table 4 Distribution of costs of osteoporosis in Florida for 2000, by site of care and age group
Age (years)
Cost ($) by site of medical care (% of total for each age group) 
TotalInpatient* Outpatient† LTC 
50–64 67,049,787 (67) 9,136,084 (9) 24,087,081 (24)  100,272,952 (100)
65–74 120,494,862 (60) 16,294,959 (8) 64,611,694 (32)  201,401,516 (100)
75–84 248,303,716 (55) 34,636,092 (8) 166,840,852 (37)  449,780,660 (100)
≥85 253,404,844 (52) 36,339,196 (7) 197,245,947 (41)  486,989,986 (100)
Total 689,253,209 (56) 96,406,332 (8) 452,785,573 (37) 1,238,445,114 (100)
*Inpatient includes acute inpatient facility and physician costs, readmissions to acute care hospitals, and costs for rehabilitation/short-stay hospitals.
†Outpatient includes medical and nonmedical home care costs, posthospital and outpatient physician visits, and other outpatient care.
Abbreviation: LTC, long-term care, which includes LTC facility costs and disability/dependency.
Estimating the Cost Burden of Osteoporosis 579
panic persons. Growth is most substantial after
2010, and by 2025 costs and fractures in Hispanic
persons are predicted to increase 2.5-fold.
Sensitivity Analysis
We assessed the impact on the base-case results
from changes in unit costs, the true rate of inﬂation,
and race-speciﬁc fracture incidence rates. For inpa-
tient charges, the cost was reduced by 30% for the
low-cost scenario and increased by 10% for the
high-cost scenario. All other costs were reduced by
25% for the low-cost scenario and increased by
25% for the high-cost scenario, as is commonly
done when measures of statistical variation are una-
vailable. The ranges in base-year total costs were
$1.08 billion under the low-cost scenario to $1.39
billion under the high-cost scenario (Table 6). The
low-to-high ranges in total cost were approximately
$1.34 billion to $1.74 billion in 2010 and $1.87
billion to $2.41 billion in 2025. When 1% was used
as the true rate of inﬂation and 3% was used as the
real interest rate, costs were estimated to be $1.26
billion in 2010 and over $1.30 billion in 2025.
When 5% was used as the true rate of inﬂation and
3% was used as the real interest rate, costs were
estimated to be $1.86 billion in 2010 and $3.45 bil-
lion in 2025. Finally, we applied alternative inci-
dence rates for spine and wrist fractures, according
to race. Hip and other fracture incidence rates were
not changed from the base case because these frac-
ture incidence rates already are race-speciﬁc based
on the estimates from Florida hospital data. An
adjustment factor of 0.33 was applied to wrist frac-
ture incidence rates for all nonwhite races [28,29],
and for spine fractures multipliers of 0.25, 0.55,
and 0.33 were used for black, Hispanic, and other
race groups, respectively [30–32]. In this scenario,
costs for 2000 were slightly lower versus the base
case, $1.230 billion versus $1.238 billion, as was
total cost growth over time. In summary, the base-
case results were generally robust when subjected to
alternative values for key parameters. As expected,
Table 5 Projected costs related to osteoporosis in Florida by fracture type, sex, and race
Cost ($) and number of fractures [in brackets] (% change from base year) 
Base year 2000 2005 2010 2025
Fracture type
Hip* 949,062,534 1,068,022,769 (12.5) 1,179,295,694 (24.3) 1,631,693,613 (71.9)
[24,004] [27,029] (12.6) [29,842] (24.3) [41,346] (72.2)
Spine* 100,202,676 110,769,217 (10.5) 122,834,236 (22.6) 176,939,783 (76.6)
[44,382] [48,914] (10.2) [54,045] (21.8) [78,332] (76.5)
Wrist* 16,913,891 19,257,994 (13.9) 22,179,745 (31.1) 30,348,606 (79.4)
[11,086] [12,584] (13.5) [14,529] (31.1) [20,056] (80.9)
Other* 172,266,013 191,755,265 (11.3) 213,115,445 (23.7) 296,148,562 (71.9)
[6,957] [7,750] (11.4) [8,609] (23.7) [11,889] (70.9)
Total* 1,238,445,114 1,389,805,245 (12.2) 1,537,425,120 (24.1) 2,135,130,564 (72.4)
[86,428] [96,276] (11.4) [107,026] (23.8) [151,622] (75.4)
Sex and race
Women† 927,086,951 1,045,311,217 (12.8) 1,159,506,256 (25.1) 1,606,233,515 (73.3)
[77,644] [86,558] (11.5) [96,361] (24.1) [136,735] (76.1)
Men† 311,358,163 344,494,028 (10.6) 377,918,865 (21.4) 528,897,049 (69.9)
[8,784] [9,718] (10.6) [10,664] (21.4) [14,887] (69.5)
White‡ 1,082,874,008 1,185,093,818 (9.4) 1,270,473,814 (17.3) 1,587,007,133 (46.6)
[73,005] [79,112] (8.4) [85,183] (16.7) [109,487] (50.0)
Black‡ 34,618,806 41,359,370] (19.5) 49,497,401 (43.0) 82,870,548 (139.4)
[3,972] [4,781] (20.4) [5,777] (45.5) [9,666] (143.4)
Hispanic‡ 99,935,232 130,007,752 (30.1) 167,738,409 (67.8) 346,030,356 (246.3)
[8,350] [10,693] (28.1) [13,625] (63.2) [26,973] (223.0)
Other‡ 21,017,068 33,344,305 (58.7) 49,715,497 (136.5) 119,222,526 (467.3)
[1,102] [1,690] (53.4) [2,440] (121.4) [5,496] (398.8)
*All races, both sexes.
†All races.
‡Both sexes.
Figure 1 Osteoporosis costs in Florida by race, 2000 through 2025.
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the long-term projections were most sensitive to
changes in the true rate of inﬂation.
Discussion
We developed a general methodology to estimate
the number of osteoporotic fractures and associated
medical costs for a given state population. A
Markov model of osteoporosis was used to create
cost estimates for hip, spine, and wrist fractures in
women. We combined these results with costs for
other fractures in women and all fractures in men
based on inpatient hospital admissions to yield total
population costs for 2000 through 2025. The
model’s ﬂexible input design enabled us to take
advantage of data available in an individual state
and supplement with national data as needed. This
methodology contrasts with a “top-down” account-
ing approach where the cost burden for an individ-
ual state is derived from national ﬁgures, failing to
account for variations in population distribution by
age, sex, and race, and medical practice patterns
among states.
Our methodology has the advantage of applica-
bility across states, providing a standardized study
design that facilitates interstate comparisons. In
contrast, three earlier studies of state inpatient data-
bases each took a different approach to identify-
ing osteoporosis-related admissions and costs. The
Illinois Department of Public Health selected
patients with a principal diagnosis of osteoporosis
or pertinent fracture but included wrist or spine
fractures only if there was a secondary diagnosis
of osteoporosis [6]. The Pennsylvania Health Care
Cost Containment Council (PHC4) studied only
patients with a diagnosis of osteoporosis [7]. The
California study included both patients with a
diagnosis of osteoporosis and those with fractures
attributable to osteoporosis [8]. The ICD-9 codes
used to select fracture cases also differed across
these studies. As a result, the Pennsylvania study [7]
found hip fractures to comprise only 21% of oste-
oporosis-related hospital admissions compared
with 78% in Illinois [6], 48% in California [8], and
68% in our analysis of Florida data. Conversely, the
Illinois study [6] found wrist and spine fractures to
comprise less than 2% of osteoporosis-related hos-
pitalizations compared to more than 26% in Penn-
sylvania [7], 11% in California [8], and 16% in
Florida. Although demographics and health-care
practices may contribute to interstate variation in
osteoporosis-related hospital admissions, methodo-
logic differences probably account for the wide
range in these results.
We found that hospitalization contributed more
than half of total medical costs in Florida in 2000,
with hip fractures driving those expenditures. The
distribution of cost by site of service was 56% for
inpatient, 8% for outpatient, and 37% for LTC.
These proportions are similar to national estimates
by Ray et al. [1] of 62%, 9%, and 28%, using 1992
hospital data and 1985 LTC facility data. The lower
inpatient share and higher LTC share in Florida may
reﬂect changes in practice patterns over the past
decade. Hospitals have had strong incentives to
minimize hospital days and discharge patients to
skilled LTC facilities or other types of follow-up
care. Shen et al. [6] reported a steady decrease in
average length of stay for osteoporosis-related hos-
pitalizations in Illinois from 1992 (10.1 days)
through 1995 (7.4 days), along with an increase in
discharges to LTC facilities. In California, Max et
al. [8] found that LTC facilities represented the
majority (59%) of total costs in 1998. Inpatient and
outpatient care, including home health, each con-
tributed approximately 20% of total costs. These
relatively high LTC and outpatient costs might be
explained in part by California’s managed care envi-
ronment. However, Max et al. [8] derived these
costs from national data sources such as the 1996
Table 6 Sensitivity analysis of total costs of osteoporosis in Florida for 2000, 2005, 2010, and 2025, using low and high unit
costs, low and high true rate of inﬂation, and race-speciﬁc fracture incidence rates
Scenario
Year 
2000 2005 2010 2025
Base case* 1,238,445,114 1,389,805,245 1,537,425,120 2,135,130,564
Low-cost case* 1,081,131,525 1,212,491,014 1,341,586,697 1,869,276,948
High-cost case* 1,397,018,821 1,569,034,933 1,736,127,215 2,409,776,674
Base case
i = 1%; r = 3% 1,238,445,114 1,260,012,030 1,263,675,203 1,307,760,346
i = 5%; r = 3% 1,238,445,114 1,530,080,633 1,863,437,008 3,453,236,292
Race-speciﬁc fracture incidence rates† 1,230,978,859 1,380,349,030 1,525,505,703 2,112,586,120
*Assumes both true rate of inﬂation, i, and real rate of interest, r, equal 3%.
†Base-case fracture incidence rates multiplied by 0.25, 0.55, and 0.33 for Black, Hispanic, and other, respectively, for spine fracture; and 0.33 for wrist fracture (all
nonwhite races).
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Medical Expenditure Panel Survey and the 1997
National Nursing Home Survey, rather than Cali-
fornia data. Further research is needed to evaluate
differences in databases and their implications for
osteoporosis costs.
This analysis may underestimate total costs and
fractures as a result of several limitations and con-
servative assumptions. First, only costs of medical
care and direct nonmedical care were included in
our analysis. Costs of unpaid caregiver time, for
example, were not estimated. Second, the analysis
excluded individuals less than 50 years of age,
although glucocorticoid-induced osteoporosis often
occurs in younger age groups. Third, inpatient costs
were based only on hospital cases with fractures as
a primary diagnosis. Recent research on comorbid
costs of spine fractures, as secondary diagnoses,
suggests that hospital stays are extended by 2 to
3 days [33,34]. In the study by Max et al. [8], more
than 22% of total hospital costs were derived from
excess costs of osteoporosis as a secondary diagno-
sis. Fourth, our analysis did not fully capture costs
of osteoporosis that were not driven by fractures,
such as LTC facility admissions owing to frailty,
kyphosis, or pressure on other organs. Fifth, the use
of constant relative resource prices over time repre-
sents an extremely conservative assumption because
medical care costs have been growing faster than
the economy-wide rate of inﬂation for several dec-
ades. On the other hand, in our base case analysis,
we applied a cost-to-charge-ratio (CCR) of 0.8, for
example, a 20% discount, to inpatient hospital
charges. The use of a lower CCR would lead to
lower unit costs of fractures. We attempted to
address the uncertainty around all unit cost inputs
through our sensitivity analyses. Furthermore, our
methodology can easily accommodate newer or
more precise unit cost estimates as they become
available.
An important limitation is the method of estimat-
ing other fractures and all fractures in men. The
Markov model was not used for these fracture
events because we lacked overall incidence data.
Our cost data represent only current year costs for
incident fracture events that were related to an inpa-
tient hospital episode. Most spine and wrist frac-
tures do not result in a hospital admission; but
many do require medical attention such as physi-
cian visits, medical supplies, and drugs. Thus, the
total number and costs of these fractures in men are
clearly underestimated. Another limitation of this
analysis is the combined use of Florida and national
data and the accompanying assumptions for esti-
mating the costs per fracture type. Our description
of hospital fracture admissions and discharges to
LTC begins to elucidate how the cost structure and
osteoporosis practice patterns in Florida differ from
the rest of the nation.
Conclusions
On balance, this analysis provides conservative esti-
mates of the total cost of osteoporosis in Florida.
Our base case probably forms a lower bound on
total costs. Nonetheless, the costs are staggering
and are estimated to grow from $1.24 billion in
2000 to $2.14 billion in 2025. Costs of osteoporotic
fractures in Hispanic persons are projected to
increase 2.5-fold. The richness of information gen-
erated by our methodology should assist policy
makers in planning for future health service needs,
such as increasing demand for LTC. In addition, our
ﬁndings may help target interventions to rein in bur-
geoning osteoporosis costs by increasing diagnosis
and treatment of osteoporosis in older Floridians at
high risk of fracture. For example, culturally appro-
priate interventions may be valuable in preventing a
dramatic increase in osteoporotic fractures in His-
panic persons. This methodology can also be used
for cost derivation in other states and provides
a standardized means for making comparisons
among states.
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Appendix 1
Data Sources and Assumptions for Hip Fractures in Florida
Cost category Source Assumptions and comments
Inpatient .
Acute inpatient
hospital
1998 FL AHCA 
Hospital Inpatient Data File*
Imposed high-cost outlier trim of $200,000. Reduced mean charges by 20% to 
reﬂect payer discounts and contractual adjustments. Included emergency
department costs.
Acute inpatient
physician services
1994 US OTA [20] Reduced by 20% to reﬂect payer discounts.
Rehabilitation/
short-stay hospital
1998 NOF [21] Assumed 12% of patients entered rehabilitation/short-stay hospital for average
of 9 days within 1 year of event and mean cost $8561.
Readmit to acute
inpatient hospital
1998 NOF [21] Assumed 8% of patients readmitted to short-term acute hospital for average of
8 days within 1 year of event. Multiplied original hospital admission by 48.5%
for age 50 to 64 years and 59% for age 65+ years. 
Outpatient
Home care 1998 NOF [21] Assumed 30% probability of 6 months of care. Included cost of nursing services, 
rehab services, and DME at patient’s home.
Nonmedical home care 1998 NOF [21] Assumed 17% use by people with hip fractures. Included cost of social worker
services, special transportation services, meal delivery, etc.
Posthospital/outpatient
physician visits
1998 NOF [21] Assumed eight visits after hospital discharge.
Other outpatient care Ray et al. [1] Outpatient hospital and “other” outpatient services (physical therapy, diagnostic
radiology, medications, orthopedic and other supplies). Multiplied mean
inpatient care costs by 1.8% (proportion of other outpatient to inpatient care
costs).
LTC
LTC facility 1998 NOF [21] and
1998 FL AHCA
Multiplied discharge rates to Florida LTCF, by age group, by length of stay in LTC
facility and cost per day based on annual cost of $45,260. Discharge rate (%) to
LTCF for < 1-year or = 1-year stay:
Discharge rate (%) to LTCF, by length of stay
Women Men
Age (years) <1 year =1 year <1 year =1 year
50–64 21.0 10.5 20.4 10.2
65–74 34.7 17.4 33.7 16.4
75–84 41.6 20.8 38.6 19.3
85+ 45.6 22.8 43.1 21.5
Disability, long-term 1998 NOF [21] Assumed 27% of people with hip fracture incurred disability costs such as DME
and additional 28% had moderate disability costs (rehabilitation, nurses,
nurses aides, social workers, home aides, special transportation, and meal
delivery).
*Updated to year 2000 with medical component of the Consumer Price Index (US Bureau of Labor Statistics).
Abbreviations: AHCA, Technology agency for Health Care Administration; DME, durable medical equipment; LTC, long-term care; NOF, National Osteoporosis
Foundation; OTA, Ofﬁce of Technology Assessment.
